A recent study reveals that people who stop using popular GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Findings released in a prominent health publication points out that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing such treatments should be aware of the potential of fast rebound weight gain when the treatment is stopped," stated expert Dr. Susan Jebb.
That rate of regain means a return to starting mass within about a year and a half.
Analyzing Treatments
The analysis, which examined dozens of trials involving thousands of patients, contrasted the results of the injectable medications with older methods.
Researchers emphasize that people who shed pounds through lifestyle changes alone usually have a slower weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Experts believe the mode of action of the drugs is key to understanding the accelerated weight return.
The injections imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication means hunger is uncontrolled, making overeating much more probable."
A Lifelong Issue?
The NHS suggest the injections for people with obesity-related health risks, alongside recommended lifestyle changes.
Many experts contend that, considering the significant potential of relapse, the therapy should be considered life-long.
This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the chronic nature of excess weight," akin to managing diseases like hypertension.
Patient Experiences
People who have stopped the jabs describe a intense return of cravings.
"It was like a switch that goes on and you become starving," described one woman.
The struggle is exacerbated if individuals have not developed lasting lifestyle or habit modifications during treatment.
Widespread Adoption
Figures suggest that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is higher among women than men.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Finally, researchers stress that while these medications are potent tools for weight loss, they are not a standalone fix and long-term success likely depends on combined lifestyle changes.